Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HALO | EXEL | CYTK | ||
| Company | Halozyme Therapeutic | Exelixis Inc | Cytokinetics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 52.05 | 21.96 | 54.61 | ||
| High | 52.50 | 22.17 | 55.65 | ||
| Low | 51.36 | 21.87 | 53.68 | ||
| Last | 51.56 | 22.10 | 55.51 | ||
| Change | -0.45 | +0.14 | +1.11 | ||
| % Change | -0.87% | +0.64% | +2.04% | ||
| Volume | 741,961 | 630,313 | 959,381 | ||
| 20-Day Average Volume | 1,595,063 | 1,592,901 | 1,990,674 | ||
| Previous Close | 52.01 | 21.96 | 54.40 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 51.09 | 22.08 | 53.46 | ||
| 20-Day Raw Stochastic | 71.82% | 54.01% | 93.06% | ||
| 20-Day Relative Strength | 63.84% | 51.48% | 49.87% | ||
| Weighted Alpha | +49.97 | +10.31 | -7.74 | ||
| Today's Opinion | 100% Buy | 8% Buy | 56% Sell | ||
| Previous Opinion | 100% Buy | 24% Sell | 56% Sell | ||
| Last Month's Opinion | 100% Buy | 16% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.14% since 06/27/24 | -1.91% since 06/27/24 | +3.22% since 06/27/24 | ||
| Low | 50.68 on 07/02/24 | 21.82 on 07/03/24 | 52.94 on 06/28/24 | ||
| High | 53.22 on 07/01/24 | 22.73 on 07/01/24 | 55.86 on 07/01/24 | ||
| 1-Month | |||||
| %Chg | +12.95% since 06/05/24 | +0.64% since 06/05/24 | +1.70% since 06/05/24 | ||
| Low | 47.33 on 06/06/24 | 21.36 on 06/20/24 | 50.81 on 06/26/24 | ||
| High | 53.22 on 07/01/24 | 22.73 on 07/01/24 | 55.86 on 07/01/24 | ||
| 3-Month | |||||
| %Chg | +25.54% since 04/05/24 | -4.49% since 04/05/24 | -23.66% since 04/05/24 | ||
| Low | 37.73 on 04/19/24 | 20.14 on 05/29/24 | 46.25 on 05/28/24 | ||
| High | 53.22 on 07/01/24 | 23.89 on 04/29/24 | 75.71 on 04/09/24 | ||
| 6-Month | |||||
| %Chg | +46.81% since 01/05/24 | -4.91% since 01/05/24 | -40.78% since 01/05/24 | ||
| Low | 33.15 on 02/05/24 | 19.20 on 01/08/24 | 46.25 on 05/28/24 | ||
| High | 53.22 on 07/01/24 | 24.07 on 03/21/24 | 110.25 on 01/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,619,521 | 6,658,272 | 5,704,057 | ||
| Shares Outstanding, K | 127,274 | 303,200 | 104,854 | ||
| Annual Sales | 829,250,000 | 1,830,210,000 | 7,530,000 | ||
| Annual Net Income | 281,590,000 | 207,770,000 | -526,240,000 | ||
| Last Quarter Sales | 195,880,000 | 425,230,000 | 840,000 | ||
| Last Quarter Net Income | 76,820,000 | 37,320,000 | -135,640,000 | ||
| 60-Month Beta | 1.27 | 0.54 | 0.75 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.79 on 05/07/24 | 0.17 on 04/30/24 | -1.33 on 05/08/24 | ||
| Latest Earnings Date | 08/13/24 | 08/06/24 | 08/01/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 18.13 | 34.61 | 0.00 | ||